Becerra, N. A. P. U. J., Cañón, M. P. U. J., & Vivas, J. M. P. U. J. (2010). choline receptor partial agonist vs. sustained-release bupropion and placebo for smoking cessation. JAMA 2006; 296(1): 47-55. 47. Kessler RC, Berglund PA, Borges G, Castilla-Puentes RC, Glantz MD, Jaeger SA, et al. Smoking and suicidal behaviors in the Nat. Pontificia Universidad Javeriana.
Citación Chicago StyleBecerra, Nelci Astrid; Pontificia Universidad Javeriana, Martín; Pontificia Universidad Javeriana Cañón, and José Manuel; Pontificia Universidad Javeriana Vivas. Choline Receptor Partial Agonist Vs. Sustained-release Bupropion and Placebo for Smoking Cessation. JAMA 2006; 296(1): 47-55. 47. Kessler RC, Berglund PA, Borges G, Castilla-Puentes RC, Glantz MD, Jaeger SA, Et Al. Smoking and Suicidal Behaviors in the Nat. Pontificia Universidad Javeriana, 2010.
Cita MLABecerra, Nelci Astrid; Pontificia Universidad Javeriana, Martín; Pontificia Universidad Javeriana Cañón, and José Manuel; Pontificia Universidad Javeriana Vivas. Choline Receptor Partial Agonist Vs. Sustained-release Bupropion and Placebo for Smoking Cessation. JAMA 2006; 296(1): 47-55. 47. Kessler RC, Berglund PA, Borges G, Castilla-Puentes RC, Glantz MD, Jaeger SA, Et Al. Smoking and Suicidal Behaviors in the Nat. Pontificia Universidad Javeriana, 2010.